Zhongnan Medical Journal Press

Home Results

A total of 1636 result was found. Results

A case report of immune-related multisystem adverse reactions caused by tislelizumab

Published on Chinese Journal of Pharmacoepidemiology 2025,34(3):359-364.
2570 times 374 times

SONG Qiuyan TAI Qirui ZHANG Bikui LUO Zhiying SUN Bao LIU Wenhui

Tislelizumab Myasthenia gravis Myositis Myocarditis Liver function damage Immune-related adverse reaction
Details
Revision process of the Guide on Methodological Standards in Pharmacoepidemiology in China (2nd edition)

Published on Chinese Journal of Pharmacoepidemiology 2025,34(2):121-135.
2216 times 315 times

YAN Jinan WU Yunxiao NIE Xiaolu ZHAO Houyu ZHAN Siyan SUN Feng

Pharmacoepidemiological research Methodology Guidelines Expert consultation Consensus
Details
Construction and validation of a predictive model for montelukast sodium-related adverse reactions in children with community-acquired pneumonia

Published on Chinese Journal of Pharmacoepidemiology 2025,34(2):136-143.
2185 times 295 times

SUN Mengmeng ZHU Lin WANG Zongyan ZHOU Bi

Montelukast sodium Community-acquired pneumonia Adverse drug reactions Influence factor Prediction model
Details
Penyan pill combined with thunder fire moxibustion in patients with sequelae of pelvic inflammatory disease: a randomized controlled trial

Published on Chinese Journal of Pharmacoepidemiology 2025,34(2):144-150.
2306 times 256 times

HU Yi YU Yanlan TANG Li

Penyan pill Thunder fire moxibustion Sequelae of pelvic inflammatory disease Randomized controlled trial
Details
Retrospective study of diclofenac sodium in combination with tramadol for preemptive analgesia in outpatient menopausal women undergoing IUD removal

Published on Chinese Journal of Pharmacoepidemiology 2025,34(2):151-156.
2125 times 277 times

WANG Qun ZHANG Qing HUANG Wei

Postmenopausal women intrauterine device removal Diclofenac sodium Tramadol Preemptive analgesia
Details
Signals mining and analysis of adverse drug events in minors using recombinant human growth hormone based on the FAERS database

Published on Chinese Journal of Pharmacoepidemiology 2025,34(2):157-165.
2562 times 332 times

DONG Jiaxiao WANG Yilei LI Xiuzheng LI Jie XU Yichun XU Xiaodong

Recombinant human growth hormone Data mining Adverse drug events Minors Pharmacovigilance
Details
Signal mining and analysis of adverse events for lecanemab based on the FAERS database

Published on Chinese Journal of Pharmacoepidemiology 2025,34(2):166-174.
2156 times 297 times

ZHANG Wen LI Min LIU Erping TAO Wenting CAI Rui ZHOU Weixian

Lecanemab FAERS database Drug adverse events Signal mining
Details
Study of the effect of Banxia Xiexin decoction on glucose and lipid metabolism and modulation of pancreatic sweet taste receptor signaling pathway in pre-diabetic rats

Published on Chinese Journal of Pharmacoepidemiology 2025,34(2):182-190.
2326 times 310 times

ZHOU Liang SONG Xiudao

Banxia Xiexin decoction Pre-diabetes Insulin secretion Sweet taste receptor
Details
Safety of disialoganglioside targeted therapies in the treatment of pediatric neuroblastoma: a systematic review and Meta-analysis

Published on Chinese Journal of Pharmacoepidemiology 2025,34(2):191-204.
2240 times 271 times

XING Ying PANG Yu ZHAN Siyan

Disialoganglioside Neuroblastoma Safety Systematic review Meta-analysis
Details
Shandong expert consensus on comprehensive clinical evaluation of sodium-glucose cotransporter 2 inhibitors

Published on Chinese Journal of Pharmacoepidemiology 2025,34(2):205-215.
2683 times 698 times

ZHAO Quan

Sodium-glucose cotransporter 2 inhibitor Comprehensive clinical evaluation Expert consensus
Details
Research progress on the application and safety of botulinum toxin type A during pregnancy

Published on Chinese Journal of Pharmacoepidemiology 2025,34(2):216-223.
2136 times 351 times

LIU Yanan CHENG Hong

Botulinum toxin type A Safety in pregnancy Birth defects Botulinum antitoxin
Details
Pharmaceutical practice in the management of pulmonary infection with Nocardia terpenica by clinical pharmacists

Published on Chinese Journal of Pharmacoepidemiology 2025,34(2):224-230.
2061 times 271 times

WU Qingrong ZHANG Lihua ZHANG Yu YANG Yuting ZHANG Hao GONG Xiangwen SONG Xiaobing

Nocardia terpenica Pulmonary infection Anti-infective treatment Bone marrow suppression Clinical pharmacist Pharmaceutical care
Details
A case report of ischemic bowel disease caused by Shengxuexiaoban capsules

Published on Chinese Journal of Pharmacoepidemiology 2025,34(2):236-240.
2181 times 291 times

XU Cuilin LI Binbin HU Jing HU Naizhong WANG Yanyan

Shengxuexiaoban capsules Ischemic bowel disease Adverse reactions
Details
Prediction of antibacterial mechanism of Xiaoyan Kangjun tablets based on network pharmacology and molecular docking

Published on Frontiers in Pharmaceutical Sciences 2025,29(2):181-191.
2355 times 386 times

JIN Dan SHEN Bingzheng WANG Yingyin ZHOU Benhong

Xiaoyan Kangjun tablets Network pharmacology Target Antibacterial Anti-inflammatory Molecular docking
Details
Exploration of the effect and mechanism of Jianpi Yishen formula on renal anemia in rats based on the network pharmacology and animal validation

Published on Frontiers in Pharmaceutical Sciences 2025,29(2):192-200.
1864 times 267 times

LI Changhui LAI Zhenqin CHEN Qiugu WANG Rui ZHANG Shangbin LI Shunmin LIU Zhicheng CHEN Jianping

Jianpi Yishen formula Renal anemia Epidermal growth factor receptor Network pharmacology HPLC-QQQ-MS/MS Chronic kidney disease
Details